[
  {
    "ts": "2025-08-11T13:10:00+00:00",
    "headline": "3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates",
    "summary": "Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.",
    "url": "https://finance.yahoo.com/news/3-biotech-stocks-likely-outpace-131000878.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c987577f-1dd4-3e17-a754-ba23b3bdfe0a",
      "content": {
        "id": "c987577f-1dd4-3e17-a754-ba23b3bdfe0a",
        "contentType": "STORY",
        "title": "3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates",
        "description": "",
        "summary": "Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.",
        "pubDate": "2025-08-11T13:10:00Z",
        "displayTime": "2025-08-11T13:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/huVQAxApMqB.EnhvDFmmKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AOhBEAisdCF50xeLb4f6kA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-biotech-stocks-likely-outpace-131000878.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-11T11:00:00+00:00",
    "headline": "Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments",
    "summary": "Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2025, and provided a review of recent accomplishments and anticipated upcoming developments.",
    "url": "https://finance.yahoo.com/news/biohaven-reports-second-quarter-2025-110000699.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b3f3979f-f96f-30ac-a7f8-744b13a3f069",
      "content": {
        "id": "b3f3979f-f96f-30ac-a7f8-744b13a3f069",
        "contentType": "STORY",
        "title": "Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments",
        "description": "",
        "summary": "Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2025, and provided a review of recent accomplishments and anticipated upcoming developments.",
        "pubDate": "2025-08-11T11:00:00Z",
        "displayTime": "2025-08-11T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/97c920f549c08730efa2caa3d86a161a",
          "originalWidth": 400,
          "originalHeight": 117,
          "caption": "(PRNewsfoto/BIOHAVEN LTD)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hIv0NRL3xMhPg_WqkzcOCg--~B/aD0xMTc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/97c920f549c08730efa2caa3d86a161a.cf.webp",
              "width": 400,
              "height": 117,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DfK882lxucMoRhFHuM8zJA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/97c920f549c08730efa2caa3d86a161a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biohaven-reports-second-quarter-2025-110000699.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biohaven-reports-second-quarter-2025-110000699.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BHVN"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]